Literature DB >> 10404917

Lyme disease serology: problems and opportunities.

G P Wormser, M E Aguero-Rosenfeld, R B Nadelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10404917     DOI： 10.1001/jama.282.1.79

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Lyme borreliosis in Ontario: determining the risks.

Authors:  I K Barker; L R Lindsay
Journal:  CMAJ       Date:  2000-05-30       Impact factor: 8.262

Review 2.  Laboratory testing for Lyme disease: possibilities and practicalities.

Authors:  Kurt D Reed
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.

Authors:  Paul M Arnaboldi; Mariya Sambir; Raymond J Dattwyler
Journal:  Clin Vaccine Immunol       Date:  2014-08-13

4.  Borrelia burgdorferi B31 Erp proteins that are dominant immunoblot antigens of animals infected with isolate B31 are recognized by only a subset of human lyme disease patient sera.

Authors:  J C Miller; N El-Hage; K Babb; B Stevenson
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 5.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Seroprevalence of Borrelia burgdorferi in Romania.

Authors:  A Hristea; S Hristescu; C Ciufecu; A Vasile
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

Authors:  Giacomo Signorino; Paul M Arnaboldi; Mary M Petzke; Raymond J Dattwyler
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

8.  Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.

Authors:  M F Seidel; A Belda Domene; H Vetter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

9.  The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.

Authors:  Catherine A Brissette; Evelyn Rossmann; Amy Bowman; Anne E Cooley; Sean P Riley; Klaus-Peter Hunfeld; Michael Bechtel; Peter Kraiczy; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

10.  Borrelia burgdorferi-specific IgA in Lyme Disease.

Authors:  Christina D'Arco; Raymond J Dattwyler; Paul M Arnaboldi
Journal:  EBioMedicine       Date:  2017-04-21       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.